Observational Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11300-11310
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11300
Table 4 Percentage of sites with clinical attachment loss ≤ 3 mm, 4-5 mm and ≥ 6 mm among well-controlled type 2 diabetes mellitus group, uncontrolled type 2 diabetes mellitus group without microvascular complications and uncontrolled type 2 diabetes mellitus group with microvascular complications
Variable, CAL
Group I (% of site)
Group II (% of site)
Group III (% of site)
P valuea
CAL ≤ 3 mm75.0747.6443.67< 0.001
CAL 4-5 mm22.1637.5338.43< 0.001
CAL ≥ 6 mm2.7714.8317.90< 0.001